Next Article in Journal
Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease
Next Article in Special Issue
Complement Component C1q as a Potential Diagnostic Tool for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Subtyping
Previous Article in Journal
Patient-Reported Outcome Measurements in Temporomandibular Disorders and Headaches: Summary of Measurement Properties and Applicability
Previous Article in Special Issue
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
 
 
Article

Article Versions Notes

J. Clin. Med. 2021, 10(17), 3826; https://doi.org/10.3390/jcm10173826
Action Date Notes Link
article pdf uploaded. 26 August 2021 11:30 CEST Version of Record https://www.mdpi.com/2077-0383/10/17/3826/pdf-vor
article supplementary file uploaded. 26 August 2021 11:30 CEST - https://www.mdpi.com/2077-0383/10/17/3826#supplementary
article xml file uploaded 30 August 2021 07:01 CEST Original file -
article xml uploaded. 30 August 2021 07:01 CEST Update https://www.mdpi.com/2077-0383/10/17/3826/xml
article pdf uploaded. 30 August 2021 07:01 CEST Updated version of record https://www.mdpi.com/2077-0383/10/17/3826/pdf
article html file updated 30 August 2021 07:03 CEST Original file -
article html file updated 28 July 2022 07:57 CEST Update https://www.mdpi.com/2077-0383/10/17/3826/html
Back to TopTop